Akero Therapeutics shares traded near their all-time high as the drugmaker reported positive results in a study of its treatment for liver disease.

Akero Therapeutics shares gained 106% before the bell on Monday after the company reported results from a mid-stage trial studying its lead drug in patients with a type of liver disease.

Multidisciplinary care is needed to ensure positive maternal and fetal health outcomes, especially in complex or high-risk ...

The (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Those prescribed the painkiller twice in the space of six months had a far increased risk of a number of serious health ...

A train car derailed and crashed into the Marys River after the structural failure of a trestle on Saturday afternoon in Corvallis. The train, operated by Portland & Western Railroad, was carrying ...

Hepatitis E, a potentially serious viral liver disease, is transmitted through contaminated water. The risk is particularly high in populations with limited access to safe water and sanitation. In ...

Objective: This network meta-analysis was to compare the efficacy of different drugs on cardiac function, renal function, and clinical outcomes in patients with acute heart failure (AHF) accompanied ...

One system indirectly impacted by liver disease is the central nervous system, and most specifically the brain. During an acute or chronic hepatitis infection, toxic substances from the liver can ...

Chronic inflammation ... It can follow an acute form of inflammation or be a prolonged low-grade form. The gut–liver axis is of crucial importance in health and disease. TM6SF2 is a genetic ...